Post-release Retention in HIV Care for Ex-inmates in South Africa

March 31, 2021 updated by: Johns Hopkins University

Corrections2Community: Post-release Retention in HIV Care for Ex-inmates in South Africa

HIV remains the leading cause of death in South Africa as a result of a failure of people living with HIV to seek HIV treatment and be retained in care. After initiating antiretroviral therapy while incarcerated, most ex-inmates fail to remain engaged in care. The goal of this research is to reduce mortality, morbidity, and HIV transmission by developing an actionable approach to retaining these individuals in HIV care.

Study Overview

Status

Completed

Conditions

Detailed Description

To pilot a randomized clinical trial (RCT) of a transition adherence club (TCAC) versus traditional care, among ex-inmates receiving antiretroviral therapy in South Africa, to study feasibility, acceptability, and preliminary effectiveness using mixed methods.

Investigators will pilot an RCT of the TCAC compared to traditional care among inmates/ex-inmates measuring transition in care, six-month viral load suppression, and follow-up of participants. Feasibility will be assessed by process measures. Acceptability will be assessed using in-depth interviews among 36 participants and 10 staff. Effectiveness will be assessed by a difference in proportions in-care with an undetectable viral load at 6 months and difference in bonding social capital and care satisfaction between arms.

Study Type

Interventional

Enrollment (Actual)

176

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pretoria
      • Pretoria West, Pretoria, South Africa, 0001
        • Department of Correctional Services

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently incarcerated (either an offender/sentenced inmates or awaiting trial inmate/remandee)
  • Housed at one of the study correctional facilities (including participating satellite centres)
  • Diagnosed with HIV
  • Currently receiving antiretroviral therapy
  • Anticipated release or trial date within 3 months of study enrollment
  • Self-report expected to reside within Ekurhuleni, Tshwane, or Johannesburg districts of Gauteng Province and within proximity to one of the TCAC sites (within 20 km, 45 minute travel time, or two local taxi minibus rides)
  • Agree to post-discharge follow-up
  • Medically stable based on DCS health assessment (including not pregnant)
  • On antiretroviral therapy (ART) for >3 months at the expected time of corrections release

Exclusion Criteria:

  • Failure to provide informed consent to be followed up by study staff after release
  • Unable to speak one of the study languages (English, Sesotho, isiXhosa, isiZulu, Setswana, Xitsonga, and Afrikaans)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transition Community Adherence Club (TCAC)
Participants in this arm will be referred to join a facilitated group setting for HIV on release from incarceration. This arm will provide HIV care services in a facilitated group setting to provide medical and psychosocial needs of participants.
A behavioral intervention targeting stigma and care challenges through care delivery, social capital through a group setting, improved job prospects through referrals and training, and substance use through referrals. Participants assigned to this group will meet at least every month in a group of 5-15 members for approximately 2 hours. During the meeting there will be facilitated group discussion, an interactive curriculum including life skills, economic skills, HIV and health, and disclosure and stigma. Individual health screening and distribution of prepackaged medications conclude the session. Individual referrals for specific services (e.g. mental health or substance use management) will be available.
Other Names:
  • Transition Community Adherence Club
No Intervention: Care as usual (CAU)
Care as usual participants will be referred to routine clinic HIV care on release from corrections.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants in Care at Six Months
Time Frame: 6 months after corrections release
Self-reported in TCAC or routine DoH clinical care
6 months after corrections release

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of Participants Verified in Care at Six Months
Time Frame: 6 months after corrections release
Clinical record (electronic or paper) verified in care
6 months after corrections release
Time to Linkage to HIV Care
Time Frame: 6 months after corrections release
Number of days from end of intervention to first clinic visit
6 months after corrections release
Proportion of Participants Linked to Care Within 90 Days of Corrections Release
Time Frame: 90 days after corrections release
Self-reported in TCAC or DoH clinical care
90 days after corrections release
Viral Suppression (HIV RNA <400 c/mL) at Six Months
Time Frame: 6 months after corrections release
Viral load data at 6 months will be based on routinely collected viral load data (clinic records and the electronic National Health Laboratory System to determine 6 month viral load outcomes, successfully applied in prior studies) augmented by viral loads obtained by the study when 6 month viral load data are not available.
6 months after corrections release
Difference in Bonding Social Capital Score at Six Months
Time Frame: 6 months after corrections release
Assessed using a 12-item scale with a higher score indicating greater bonding social capital. The median scores will be compared. Range 0-48.
6 months after corrections release
Difference in HIV Stigma Index Score at Six Months
Time Frame: 6 months after corrections release
Assessed using 28-item Berger stigma scale with median score used per stigma construct (internalized, anticipated, experienced). Higher values indicate more stigma. Ranges: experienced 38; anticipated 6; internalized 6.
6 months after corrections release
Proportion of Participants Employed or Self-employed
Time Frame: 6 months after corrections release
Self-reported employment
6 months after corrections release
Feasibility of Implementation of Transition Community Adherence Clubs Per Protocol (Composite Score)
Time Frame: 6 months after corrections release
Feasibility of implementation will be assessed based on the proportion of participants meeting the following intervention milestones: TCAC visit, 6-month social capital questionnaire and stigma scale, and 6-month viral load ascertainment. The proportion of participants in the intervention arm who have completed all of these components with by used as a composite score (range 0-1)
6 months after corrections release
Acceptability of Transition Community Adherence Clubs
Time Frame: 6 months after corrections release
Qualitative outcome assessed using in-depth interviews exploring participant views on the acceptability of the transition community adherence clubs. This is a qualitative analysis based on thematic coding.
6 months after corrections release
Difference in Ex-inmate Stigma Index Score at Six Months
Time Frame: 6 months after corrections release
Assessed using 28-item hybrid (study specific) stigma scale with median score used per stigma construct (internalized, anticipated, experienced). Higher values indicate more stigma. Higher values indicate more stigma. Ranges: experienced 38; anticipated 6; internalized 6.
6 months after corrections release

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 9, 2019

Primary Completion (Actual)

August 1, 2020

Study Completion (Actual)

November 30, 2020

Study Registration Dates

First Submitted

November 8, 2017

First Submitted That Met QC Criteria

November 9, 2017

First Posted (Actual)

November 13, 2017

Study Record Updates

Last Update Posted (Actual)

April 27, 2021

Last Update Submitted That Met QC Criteria

March 31, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00181117
  • 1R34MH115777 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified trial data will be made available one year after completion of all study activities.

IPD Sharing Time Frame

One year after completion of study activities.

IPD Sharing Access Criteria

Contact PI

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hiv

Clinical Trials on Transition Community Adherence Club (TCAC)

3
Subscribe